Roquette Strategically Acquires IFF Pharma Solutions

Roquette, a plant-based ingredients and pharmaceutical excipients manufacturer, announced today an agreement to acquire IFF Pharma Solutions, an excipients for oral dosage solutions producer, to reinforce its position as a major partner to the pharmaceutical industry.

The merger of the two businesses will refocus the company on Health and Nutrition, broaden its pharmaceutical offerings, and boost Roquette’s growth significantly.

IFF, based in New York, USA, is a leading producer of excipients for oral dosage solutions with a global presence, $1B in revenue, and ~1,100 employees. It offers a wide range of quality products to major pharmaceutical, food, and nutraceutical companies worldwide.

Roquette’s acquisition of IFF Pharma Solutions is a game-changer. It strengthens its position in the promising excipients market, boosts its presence in the US, and greatly enhances its formulation capabilities and drug delivery R&D. This move positions Roquette as the preferred partner for innovative drug delivery solutions, meeting customer needs and enhancing patient care.

Roquette and IFF target to close the transaction in the first half of 2025. Closing remains subject to regulatory clearance and satisfaction of other customary closing conditions.

Company

Logo:

Roquette

1 rue de la Haute Loge
62136 Lestrem
France

Company contact







Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.